1. Home
  2. FNWB vs SGMT Comparison

FNWB vs SGMT Comparison

Compare FNWB & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNWB
  • SGMT
  • Stock Information
  • Founded
  • FNWB 1923
  • SGMT 2006
  • Country
  • FNWB United States
  • SGMT United States
  • Employees
  • FNWB N/A
  • SGMT N/A
  • Industry
  • FNWB Banks
  • SGMT
  • Sector
  • FNWB Finance
  • SGMT
  • Exchange
  • FNWB Nasdaq
  • SGMT Nasdaq
  • Market Cap
  • FNWB 84.1M
  • SGMT 71.2M
  • IPO Year
  • FNWB 2015
  • SGMT 2023
  • Fundamental
  • Price
  • FNWB $8.41
  • SGMT $4.07
  • Analyst Decision
  • FNWB Hold
  • SGMT Strong Buy
  • Analyst Count
  • FNWB 1
  • SGMT 6
  • Target Price
  • FNWB $12.00
  • SGMT $25.67
  • AVG Volume (30 Days)
  • FNWB 15.5K
  • SGMT 353.7K
  • Earning Date
  • FNWB 07-24-2025
  • SGMT 05-08-2025
  • Dividend Yield
  • FNWB 3.22%
  • SGMT N/A
  • EPS Growth
  • FNWB N/A
  • SGMT N/A
  • EPS
  • FNWB N/A
  • SGMT N/A
  • Revenue
  • FNWB $45,593,000.00
  • SGMT N/A
  • Revenue This Year
  • FNWB $37.97
  • SGMT N/A
  • Revenue Next Year
  • FNWB $13.22
  • SGMT N/A
  • P/E Ratio
  • FNWB N/A
  • SGMT N/A
  • Revenue Growth
  • FNWB N/A
  • SGMT N/A
  • 52 Week Low
  • FNWB $8.26
  • SGMT $1.73
  • 52 Week High
  • FNWB $12.10
  • SGMT $7.38
  • Technical
  • Relative Strength Index (RSI)
  • FNWB 33.59
  • SGMT 70.27
  • Support Level
  • FNWB $8.16
  • SGMT $3.32
  • Resistance Level
  • FNWB $9.37
  • SGMT $3.85
  • Average True Range (ATR)
  • FNWB 0.27
  • SGMT 0.29
  • MACD
  • FNWB -0.08
  • SGMT 0.06
  • Stochastic Oscillator
  • FNWB 23.31
  • SGMT 95.76

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

Share on Social Networks: